Prognostic significance of submaximal negative dobutamine stress echocardiography: A 3-year follow-up study

Cardiology Journal

Volumn 15, Issue 3, 2008, Pages 237-244

  Patel, Salil J ^a   Srivastava, Ajay ^a   Lingam, Natesh ^a   Jacobsen, Gordon ^a   Ananthasubramaniam, Karthik ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

Beta blockers; Dobutamine stress echocardiography; Double product; Prognosis; Target heart rate

Indexed keywords

ATROPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DOBUTAMINE; CARDIOTONIC AGENT; DIAGNOSTIC AGENT;

AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIABETIC PATIENT; DIAGNOSTIC VALUE; DRUG DOSE ESCALATION; DRUG USE; FEMALE; FOLLOW UP; HEART DEATH; HEART DISEASE; HEART EJECTION FRACTION; HEART INFARCTION; HEART RATE; HIGH RISK PATIENT; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PHARMACOLOGIC STRESS TESTING; PROGNOSIS; STRESS ECHOCARDIOGRAPHY; SURVIVAL; EXERCISE TEST; PREDICTION AND FORECASTING; SURVIVAL RATE;

CARDIOTONIC AGENTS; DOBUTAMINE; ECHOCARDIOGRAPHY, STRESS; EXERCISE TEST; FEMALE; FOLLOW-UP STUDIES; HEART RATE; HUMANS; MALE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SURVIVAL RATE;

EID: 54049099303     PISSN: 18975593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Kamaran M, Teague SM, Finkelhor RS et al. Prognostic value of dobutamine stress echocardiography in patients referred because of suspected coronary artery disease. Am J Cardiol, 1995; 76: 887-891.
2. Poldermans D, Fioretti PM, Boersma E et al. Long-term prognostic value of dobutamine-atropine stress echocardiography in 1737 patients with known or suspected coronary artery disease: a single-center experience. Circulation, 1999; 99: 757-762.
3. Steinberg EH, Madmon L, Patel CP et al. Long-term prognostic significance of dobutamine echocardiography in patients with suspected coronary artery disease: results of a 5-year follow-up study. J Am Coll Cardiol, 1997; 29: 969-973.
4. Lauer MS, Okin PM, Larson MG et al. Impaired heart rate response to graded exercise. Prognostic implications of chronotropic incompetence in the Framingham Heart Study. Circulation, 1996; 93: 1520-1526.
5. Ballal RS, Secknus MA, Mehta R et al. Cardiac outcomes in coronary patients with submaximum dobutamine stress echocardiography. Am J Cardiol, 1997; 80: 725-729.
6. Chaowalit N, Maalouf JF, Rooke TW et al. Prognostic significance of chronotropic response to dobutamine stress echocardiography in patients with peripheral arterial disease. Am J Cardiol, 2004; 94: 1523-1528.
7. Labib SB, Goldstein M, Kinnunen PM et al. Cardiac events in patients with negative maximal versus negative submaximal dobutamine echocardiograms undergoing noncardiac surgery: importance of resting wall motion abnormalities. J Am Coll Cardiol, 2004; 44: 82-87.
8. Bonow RO. Prognostic assessment in coronary artery disease: role of radionuclide angiography. J Nucl Cardiol, 1994; 1: 280-291.
9. Marwick TH, Case C, Sawada S et al. Prediction of mortality using dobutamine echocardiography. J Am Coll Cardiol, 2001; 37: 754-760.
10. Schinkel AF, Bax JJ, Elhendy A et al. Long-term prognostic value of dobutamine stress echocardiography compared with myocardial perfusion scanning in patients unable to perform exercise tests. Am J Med, 2004; 117: 1-9.
11. Sozzi FB, Elhendy A, Roelandt JR et al. Long-term prognosis after normal dobutamine stress echocardiography. Am J Cardiol, 2003; 92: 1267-1270.
12. Elhendy A, Schinkel AF, Bax JJ et al. Prognostic value of dobutamine stress echocardiography in patients with normal left ventricular systolic function. J Am Soc Echocardiogr, 2004; 17: 739-743.
13. Tsutsui JM, Elhendy A, Anderson JR et al. Prognostic value of dobutamine stress myocardial contrast perfusion echocardiography. Circulation, 2005; 112: 1444-1450.
14. Hertzer NR, Beven EG, Young JR et al. Coronary artery disease in peripheral vascular patients. A classification of 1000 coronary angiograms and results of surgical management. Ann Surg, 1984; 199: 223-233.
15. Chen L, Ma L, de Prada VA et al. Effects of beta-blockade and atropine on ischemic responses in left ventricular regions subtending coronary stenosis during dobutamine stress echocardiography. J Am Coll Cardiol, 1996; 28: 1866-1876.
16. Iliceto S, Galiuto L, Marangelli V et al. Clinical use of stress echocardiography: factors affecting diagnostic accuracy. Eur Heart J, 1994; 15: 672-680.
17. McNeill AJ, Fioretti PM, el-Said SM et al. Enhanced sensitivity for detection of coronary artery disease by addition of atropine to dobutamine stress echocardiography. Am J Cardiol, 1992; 70: 41-46.
18. Sawada SG, Segar DS, Ryan T et al. Echocardiographic detection of coronary artery disease during dobutamine infusion. Circulation, 1991; 83: 1605-1614.
19. Srivastava A, Patel S, Lingam N, Jacobsen G, Ananthasubramanium K. Long term outcomes following negative dobutamine stress echocardiography in African Americans compared to Caucasians. J Am Soc Echocardiogr, 2007; 20: 739-743 (abstract).
20. Cortigiani L, Rigo F, Gherardi S et al. Additional prognostic value of coronary flow reserve in diabetic and nondiabetic patients with negative dipyridamole stress echocardiography by wall motion criteria. J Am Coll Cardiol, 2007; 50: 1354-1361.
21. Berry C, Tardif JC, Bourassa MG. Coronary heart disease in patients with diabetes: part I: recent advances in prevention and noninvasive management. J Am Coll Cardiol, 2007; 49: 631-642.
22. Ryden L, Standl E, Bartnik M et al. Guidelines on diabetes, prediabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J, 2007; 28: 88-136.
23. Cortigiani L, Bigi R, Sicari R, Landi P, Bovenzi F, Picano E. Prognostic value of pharmacological stress echocardiography in diabetic and nondiabetic patients with known or suspected coronary artery disease. J Am Coll Cardiol, 2006; 47: 605-610.